Rallybio
RLYB
34 hedge funds and large institutions have $420M invested in Rallybio in 2021 Q3 according to their latest regulatory filings, with 34 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
9.36% more ownership
Funds ownership: 0% → 9.36% (+9.4%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Viking Global Investors
Stamford,
Connecticut
|
+$61.5M |
| 2 |
5VM
5AM Venture Management
San Francisco,
California
|
+$61.4M |
| 3 |
TGHSA
TPG Group Holdings (SBS) Advisors
Fort Worth,
Texas
|
+$44.4M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$42.4M |
| 5 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
+$33.8M |
Top Sellers
RLYB Hedge Fund Activity: Q3 2021 in Review
34 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Rallybio (RLYB) for Q3 2021, worth a combined $420M.
Buyers outnumbered sellers: 34 funds opened new RLYB positions and 0 closed out — a net gain of 34 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Viking Global Investors, opening a new position worth an estimated $61.5M.
- 34 institutional investors held Rallybio (RLYB) as of Q3 2021, up from 0 in Q2 2021.
- Funds reported $420M of Rallybio stock for Q3 2021.
- 34 funds opened new Rallybio positions in Q3 2021 and 0 closed out, a net change of +34 holders.
- The largest Rallybio buyer in Q3 2021 was Viking Global Investors, an estimated $61.5M added.
Based on aggregated 13F filings for Q3 2021.